Free Consultations 24/7
Our law firm has been dedicated to clients like you for 90 years. We care about each one of our clients.
Cases We Handle
from auto accidents to defective product injuries to workers’ compensation claims, we’re here to help.
We value building relationships with the many people and organizations that make Cleveland a great place to live.
Our law firm has a trusted team of personal injury lawyers who have been helping injured people in Cleveland.
December 5, 2012
Three months ago, generic Lipitor was recalled by Ranbaxy because of possible mispackaging. Last week, it was again recalled by Ranbaxy Laboratories, an Indian generics plant, because of glass particles getting into the pills, according to Fierce Pharma.
Forty-one lots of atorvastin (Lipitor) in the 10, 20, and 40 mg sizes have been recalled and production halted. Ranbaxy had about 40 percent of the U.S. market for the drug.
Although the FDA says that the danger is small and no problems have been reported, the website Prevent Medical Error provides more detail than the company or the FDA. It says that Ranbaxy found foreign particles in a "powder" used for making the pills. Then the company discovered a "quarter-sized piece of the glass housing used during manufacturing was found to be missing. It was presumed that this piece of glass fell into the powder during the manufacturing process."
The FDA said that Ranbaxy has now stopped production until it gets to the bottom of its problems.
In August, the company notified retail customers that it was recalling a single lot of 10 mg atorvastatin after a customer reported finding a 20 mg tablet in a 10 mg bottle. The plant then voluntarily recalled the pills.
If you or someone you love has suffered a drug injury, the Ohio personal injury lawyers at Nurenberg, Paris, Heller & McCarthy may be able to help.
As advancements in biomedical technology continue to create new opportunities for convenient and painless solutions, more and more products are…
The Journal of the American Medical Association (JAMA) Internal Medicine study, released this month, suggests that doctors should take greater…
Viekira Pak™ and Technivie™ Liver Damage In October, the U.S. Food and Drug Administration (FDA) issued a new warning regarding a potential…